Non-nucleoside reverse transcriptase inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/06 (2006.01) A61K 31/44 (2006.01) A61P 31/18 (2006.01) C07D 471/04 (2006.01)

Patent

CA 2705834

Heteroaromatic compounds of Formula (I) are HIV reverse transcriptase inhibitors, wherein ring A is: (ii-a), (ii-b), (ii-c), (ii-d), or (ii-e); and wherein n, L, M, U, X, Y, Z, R E, R F, R1, R2A, R2B, R2C, R3, R7, R9 and R10 are defined herein. The compounds of Formula I and their pharmaceutically acceptable salts and prodrugs are useful in the inhibition of HIV reverse transcriptase, the prophylaxis and treatment of infection by HIV and in the prophylaxis, delay in the onset or progression, and treatment of AIDS. The compounds and their salts and prodrugs can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.

L'invention porte sur des composés hétéro-aromatiques, qui sont des inhibiteurs de la transcriptase inverse du VIH, de Formule (I), dans laquelle le cycle A est : (ii-a), (ii-b), (ii-c), (ii-d), ou (ii-e); et dans laquelle n, L, M, U, X, Y, Z, RE, RF, R1, R2A, R2B, R2C, R3, R8, R9 et R10 sont définis présentement. Les composés de Formule I et leurs sels acceptables du point de vue pharmaceutique et leurs promédicaments s'utilisent dans l'inhibition de la transcriptase inverse du VIH, dans la prophylaxie et le traitement d'une infection par le VIH et dans la prophylaxie, pour retarder le début ou la progression, ainsi que pour le traitement du sida. Les composés et leurs sels et promédicaments peuvent être employés comme ingrédients dans des compositions pharmaceutiques, facultativement en combinaison avec d'autres antiviraux, immunomodulateurs, antibiotiques ou vaccins.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Non-nucleoside reverse transcriptase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Non-nucleoside reverse transcriptase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-nucleoside reverse transcriptase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2075989

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.